Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01115660 · ClinicalTrials.gov registry record · NA

Stroke Education Intervention Trial - Pilot

A NA study, sponsored by Duke University.

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT01115660: Completed NA study, sponsored by Duke University.

NCT01115660 is a NA study that has completed, run by Duke University. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01115660, a NA study, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

The objectives of the trial of a medication-coach program for patients with stroke or transient ischemic attack are to pilot test the study design, the intervention components and the data collection forms and refine them for a larger trial whose goal will be to improve long-term adherence to stroke prevention medications.

Primary Outcome

Number of patients contacted at 3 months

Interventions

  • BEHAVIORAL stroke education

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2010-01
Est. Completion 2011-06
Phase NA
Duke University

1,725 total trials

What the finished NCT01115660 record still lists

NCT01115660 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which stroke education is the first listed.

NCT01115660 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01115660 about?

NCT01115660 is a clinical study titled "Stroke Education Intervention Trial - Pilot". The objectives of the trial of a medication-coach program for patients with stroke or transient ischemic attack are to pilot test the study design, the intervention components and the data collection forms and refine them for a larger trial whose goal will be to improve long-term adherence to stroke...

What is the current status of trial NCT01115660?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2010-01. Estimated completion is 2011-06.

What interventions are being tested in trial NCT01115660?

The interventions under investigation include: stroke education (BEHAVIORAL).

Who is sponsoring clinical trial NCT01115660?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01115660's enrollment target sits among peer trials

30 1593rd of 2000 higher than 299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01115660, the US trial registry maintained by the National Library of Medicine. NCT01115660 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.